Metrics as of 10/13/2026, 06:48 PM (Berlin time), refresh in progress.
medmix Stock
medmix AG
Company data
- Sector
- Industrials
- Industry
- Industrial - Machinery
- Country
- Switzerland
- CEO
- Rene Willi
- Employees
- 2,587
- Market cap
- CHF410 M
- IPO
- 04/10/2021
Established in 1922 and headquartered in Baar, Switzerland, medmix AG is a global leader in innovating, manufacturing, and distributing high-precision devices and services. The company provides solutions engineered for the controlled mixing, application, and injection of liquids across various viscosities. Medmix…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
medmix stock: price history
1D
+1.6%
1W
+3.0%
1M
+16.0%
6M
+10.3%
YTD
-10.5%
1Y
+10.7%
2Y
+1.6%
5Y
-76.7%
10Y
–
Next earnings date
Next earnings date
No date known
Volatility around earnings
~80% stronger price swings than usual
Ask the agents about medmix
medmix stock metrics
P/E
4,024
P/B
0.96
EV/EBITDA
7.99
RETURN ON EQUITY
0.1%
NET MARGIN
0.2%
DEBT/EQUITY
0.75
DIVIDEND YIELD
1.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
59.1%
FLOAT SHARES
24,062,818
AVG. DAILY VOLUME (30D)
80,062
Dividends
Comparable stocks
Frequently asked questions about medmix stock
What does medmix do?
medmix AG is a company in the Industrials sector, Industrial - Machinery industry, headquartered in Switzerland.
The CEO is Rene Willi, the company employs around 2,587 people.
The IPO was on 04/10/2021; the stock trades on SIX under the ticker MEDX.SW.
When does medmix report next?
Around past earnings, price swings were roughly 80% stronger than usual.
Does medmix pay a dividend?
Yes. The last dividend was CHF 0.10 per share, ex-date 20/04/2026, paid on 22/04/2026.
The dividend yield is 1.0% (as of 30/06/2026).
Which stocks are comparable to medmix?
Comparable stocks include Sulzer, Georg Fischer, OC Oerlikon, GE Vernova, Siemens, Siemens Energy, Parker-Hannifin and Trane Technologies.
How can I get medmix stock analyzed?
Clicking "Analyze stock" lets five strategies assess medmix against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.